Evaluation of the Association between Spironolactone Use and the Risk of Rehospitalization among Patients with Heart Failure
碩士 === 國防醫學院 === 藥學研究所 === 97 === Background: Long-term use of diuretics may cause the activation of renin-angiotentisin-aldosterone system (RAAS), induce endothelial dysfunction or cardiac remodeling, and may be associated with increased mortality in patients with heart failure (HF). Therefore, the...
Main Authors: | Wu Hsing-Hua, 吳幸樺 |
---|---|
Other Authors: | Wang Meng-Ting |
Format: | Others |
Language: | zh-TW |
Published: |
2009
|
Online Access: | http://ndltd.ncl.edu.tw/handle/40496280321400013004 |
Similar Items
-
Heart failure: preventing rehospitalizations by disease management programs
by: Valerio Verdiani, et al.
Published: (2004-06-01) -
Impact of the dosing of basic drugs on the risk of rehospitalization in patients with chronic heart failure
by: A G Arutyunov, et al.
Published: (2016-01-01) -
Relationship between Atrial Fibrillation and Use of Spironolactone in Heart Failure Patients
by: Ke-Hsin Tsao, et al.
Published: (2009) -
Rehospitalization burden and morbidity risk in patients with heart failure with mid‐range ejection fraction
by: Enrique Santas, et al.
Published: (2020-06-01) -
Furosemide and spironolactone doses and hyponatremia in patients with heart failure
by: Ivan Velat, et al.
Published: (2020-08-01)